Clinical Trials Browser

OTHER × Lung Neoplasms × Bendamustine Hydrochloride × Clear all

NCT00984542 2014-03-12

Bendamustine as Second-Line Therapy in Treating Patients With Relapsed or Refractory Small Cell Lung Cancer

Phase 2 Completed

50 enrolled 11 charts

Lung Neoplasms, Small Cell Lung Carcinoma